Literature DB >> 8490416

Hypercalcaemia associated with calcipotriol (Dovonex) treatment.

K A Hardman1, D A Heath, H M Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8490416      PMCID： PMC1677369          DOI： 10.1136/bmj.306.6882.896-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Calcipotriol and hypercalcaemia.

Authors:  C Dwyer; R S Chapman
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

2.  Topical calcipotriol treatment in advanced breast cancer.

Authors:  M Bower; K W Colston; R C Stein; A Hedley; J C Gazet; H T Ford; R C Combes
Journal:  Lancet       Date:  1991-03-23       Impact factor: 79.321

3.  Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo.

Authors:  L Binderup; E Bramm
Journal:  Biochem Pharmacol       Date:  1988-03-01       Impact factor: 5.858
  3 in total
  1 in total

1.  Hypercalcaemia with topical calcipotriol.

Authors:  J F Bourke; J Berth-Jones; P E Hutchinson
Journal:  BMJ       Date:  1993-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.